Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07706777
PHASE2

Clinical Study of HRS-2129 for Acute Gouty Arthritis

Sponsor: Shandong Suncadia Medicine Co., Ltd.

View on ClinicalTrials.gov

Summary

The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.

Official title: Clinical Study on Safety and Efficacy of HRS-2129 for Acute Gouty Arthritis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-07

Completion Date

2026-11

Last Updated

2026-07-16

Healthy Volunteers

No

Interventions

DRUG

HRS-2129 Tablet

HRS-2129 Tablet; high dose

DRUG

HRS-2129 Tablet

HRS-2129 Tablet; low dose

DRUG

Placebo

HRS-2129 Tablet Placebo

Locations (2)

The Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China